✦ LIBER ✦

1-Aminocyclopropaneboronic Acid: Synthesis and Incorporation into an Inhibitor of Hepatitis C Virus NS3 Protease

✍ Scribed by Priestley, E. Scott; Decicco, Carl P.

Book ID: 120407014
Publisher: American Chemical Society
Year: 2000
Tongue: English
Weight: 43 KB
Volume: 2
Category: Article
ISSN: 1523-7060
DOI: 10.1021/ol006284+

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pyrrolidine-5,5- trans -lactams. 1. Synt

Pyrrolidine-5,5- trans -lactams. 1. Synthesis and Incorporation into Inhibitors of Hepatitis C Virus NS3/4A Protease

✍ Andrews, David M.; Carey, Seb J.; Chaignot, Helene; Coomber, Barry A.; Gray, Nor 📂 Article 📅 2002 🏛 American Chemical Society 🌐 English ⚖ 74 KB

Detection and analysis of hepatitis C vi

Detection and analysis of hepatitis C virus NS3 serine protease inhibitors

✍ R. Zemel; L. Bachmatove; Y. Berdichevsky; M. Kunin; A. Golan-Goldhirsh; I. Benha 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 273 KB

Synthesis and Biological Activity of Mac

Synthesis and Biological Activity of Macrocyclic Inhibitors of Hepatitis C Virus (HCV) NS3 Protease.

✍ Kevin X. Chen; F. George Njoroge; Andrew Prongay; John Pichardo; Vincent Madison 📂 Article 📅 2006 🏛 John Wiley and Sons ⚖ 17 KB 👁 2 views

Solid-Phase Synthesis of Peptidomimetic

Solid-Phase Synthesis of Peptidomimetic Inhibitors for the Hepatitis C Virus NS3 Protease

✍ Poupart, Marc-André; Cameron, Dale R.; Chabot, Catherine; Ghiro, Elise; Goudreau 📂 Article 📅 2001 🏛 American Chemical Society 🌐 English ⚖ 335 KB

Inhibition of hepatitis C virus NS3 func

Inhibition of hepatitis C virus NS3 function by antisense oligodeoxynucleotides and protease inhibitor

✍ Tobias Heintges; Jens Encke; Jasper zu Putlitz; Jack R. Wands 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 249 KB

## Abstract Hepatitis C Virus (HCV) NS3 protease is an attractive target for antiviral agent development because it is required for viral replication. Because a stable cell culture system or small animal model to study HCV replication is not readily available, we constructed an in vitro model allow

Evolutionary dynamics of hepatitis C vir

Evolutionary dynamics of hepatitis C virus NS3 protease domain during and following treatment with narlaprevir, a potent NS3 protease inhibitor

✍ de Bruijne, J.; Thomas, X. V.; Rebers, S. P.; Weegink, C. J.; Treitel, M. A.; Hu 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 456 KB